Shanghai Pharmaceuticals Holding Co (S1R) Revenue

1 Followers

Shanghai Pharmaceuticals Holding Co Revenue

Shanghai Pharmaceuticals Holding Co had a revenue of 71.90B in the quarter ending Jun 30, 2026, with -3.59%. This bring the company's revenue in the last twelve months to 288.45B, Decreased 0.37%. In the fiscal year ending Dec 31, 2025, Shanghai Pharmaceuticals Holding Co had annual revenue of 283.58B with 3.03% growth.

Revenue (ttm)

288.45B

Revenue Growth

0.41%

P/S Ratio

0.03

Revenue/Employee

€5,716,409

Employees

49,608

Market Cap

€7.12B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	283.58B	8.33B	+3.03%
Dec 31, 2024	275.25B	14.96B	+5.75%
Mar 31, 2024	260.30B	28.31B	+12.21%
Dec 31, 2022	231.98B	16.16B	+7.49%
Dec 31, 2021	215.82B	23.92B	+12.46%
Dec 31, 2020	191.91B	5.34B	+2.86%
Dec 31, 2019	186.57B	27.48B	+17.27%
Dec 31, 2018	159.08B	28.24B	+21.58%
Dec 31, 2017	130.85B	―	―